Is Immedica doing their part?
Their DitchCarbon score is 51
Immedica has a DitchCarbon Score of 51 out of 100, indicating a moderate level of sustainability in its operations. This score reflects the company’s carbon intensity, which is a measure of how much carbon emissions are produced relative to its activities. A higher score would suggest a lower carbon intensity and a stronger commitment to reducing its environmental impact.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Immedica is a company in the industrial manufacturing sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Immedica is situated in Sweden, a country with a very low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by reducing the carbon footprint associated with its operations.
Unlock 30+ emissions data points on Immedica
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Immedica
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
9.71%
...this company is doing 9.71% better in emissions than the industry average.
Immedica, founded in the industrial manufacturing sector, is a prominent pharmaceutical company with a strong presence in Europe and the Middle East. Established as a fully independent entity, it specializes in delivering high-performance commercial capabilities. The company offers a range of pharmaceutical services, catering to the needs of diverse markets since its inception.
emission intelligence's platform recommendations for Immedica
Immedica could potentially reduce its emissions by 15% by investing in cleaner and more efficient machinery and equipment to enhance its Scope 1 emissions profile.
Bad news, Immedica hasn't committed to SBTi goals yet
Immedica has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company has not publicly outlined or committed to concrete targets for reducing its greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.